Traits of noncancerous cells in diffuse large B-cell lymphoma (DLBCL) tumors appear to offer insight into which patients will benefit the most from chimeric antigen receptor (CAR) T-cell therapy ...

Ultrasound is one of the most widely used imaging techniques in medicine, but up until recently it has hardly played a role in imaging the tiniest structures of our bodies, such as cells.

Imagine a super-charged immune cell that can launch a focused attack on stubborn solid tumors—a smart fighter that destroys cancer cells for days without tiring. USC biomedical engineers have ...

ABSTRACT Extraovarian granulosa cell tumors (GCTs) develop from ectopic gonadal tissue situated along the embryonal route of the genital ridge. Primary retroperitoneal tumors are extremely rare, with ...

3. Stromal Tumors Stromal tumors are a rare type of ovarian cancer that starts in the connective tissue cells that hold the ovary together and produce sex hormones, namely estrogen. These cancers tend ...

Session ID: 2025-07-04:e2b4c04bdd174845a7e4f52f Player Element ID: vjs_video_3 ...

Polycystic ovary syndrome (PCOS) is a major cause of anovulatory infertility. Laparoscopic ovarian drilling (LOD) is a treatment for PCOS that allows the laparoscopic identification of other ...

Keywords: germ cell tumors, dysgerminoma, teratoma, yolk sac, ovarian cell tumor, immunohistochemistry Citation: Bouquet de Jolinière J, Ben Ali N, Fadhlaoui A, Dubuisson JB, Guillou L, Sutter A, ...

Glioblastoma is a fast-growing and aggressive brain tumor that often kills patients within a year of diagnosis. The cancer starts in the cells called astrocytes, a type of glial or “glue cell ...

Granulosa cell tumors (GCT) are a rare subtype of ovarian cancers, characterized by a slow clinical progression and high rates of late recurrence. With limited treatment options available apart from ...

1 Introduction Ovarian granulosa cell tumor is an ovarian sex cord–stromal tumor with granulosa cell morphological characteristics and endocrine function, and it accounts for 2%–5% of all ovarian ...